Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study

Management of Salivary Gland Malignancy: ASCO Guideline

(2021) Jessica L. Geiger et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic salivary gland cancers (R/M SGCs).

(2021) Bharat Burman et al.   JOURNAL OF CLINICAL ONCOLOGY

Distant metastasis of salivary gland cancer: Incidence, management, and outcomes

(2020) Ximena Mimica et al.   CANCER

Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors

(2020) Kyriakos P. Papadopoulos et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

(2020) Aurélien Marabelle et al.   LANCET ONCOLOGY

NISCAHN: A phase II, multicenter nonrandomized trial aiming at evaluating nivolumab (N) in two cohorts of patients (pts) with recurrent/metastatic (R/M) salivary gland carcinoma of the head and neck (SGCHN), on behalf of the Unicancer Head & Neck Group.

(2019) Jerome Fayette et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC).

(2019) Vatche Tchekmedyian et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical utility of pembrolizumab in the management of advanced solid tumors: an evidence-based review on the emerging new data

(2019) Pauline du Rusquec et al.   Cancer Management and Research

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

(2019) Aurelien Marabelle et al.   JOURNAL OF CLINICAL ONCOLOGY

Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma

(2018) Roger B. Cohen et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Risk factors and prognosis for salivary gland adenoid cystic carcinoma in southern china

(2017) Dai-qiao Ouyang et al.   MEDICINE

Risk Factors and Survival Associated with Distant Metastasis in Patients with Carcinoma of the Salivary Gland

(2016) Soo Jung Nam et al.   ANNALS OF SURGICAL ONCOLOGY

High-grade histology as predictor of early distant metastases and decreased disease-free survival in salivary gland cancer irrespective of tumor subtype

(2016) Marlen Haderlein et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

(2016) Martin Reck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pembrolizumab versus Ipilimumab in Advanced Melanoma

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases

(2013) Julio Morales et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Survival from salivary glands adenoid cystic carcinoma in European populations

(2008) Laura Ciccolallo et al.   ORAL ONCOLOGY